Many cancer patients develop severe dermatitis during radiotherapy. Which factors increase the risk of such radiodermatitis has only been partially understood up until now. A pilot study at the ...
Please provide your email address to receive an email when new articles are posted on . A significant link was found between atopic/allergic conditions and a raised risk for radiodermatitis in women ...
NAPLES, Fla., Nov. 18, 2021 /PRNewswire/ - Enveric Biosciences (NASDAQ: ENVB) ("Enveric" or the "Company"), a patient-centric biotechnology company developing next-generation mental health and cancer ...
LONDON--(BUSINESS WIRE)--The global radiodermatitis treatment market is expected to post a CAGR of more than 4% during the period 2019-2023, according to the latest market research report by Technavio ...
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Radiodermatitis Market (2023-2028) by Product, Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" ...
MADISON, Wis.--(BUSINESS WIRE)--ProCertus BioPharm, Inc., an oncology-based pharmaceutical company developing therapeutics to protect cancer patients from the side effects of radiotherapy and ...
Many cancer patients develop severe dermatitis during radiotherapy. Which factors increase the risk of such radiodermatitis has only been partially understood up until now. A pilot study at the ...
Many cancer patients develop severe dermatitis during radiotherapy. Which factors increase the risk of such radiodermatitis has only been partially understood up until now. A pilot study at the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results